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Abstract  
   
  
A growing literature argues that mental well-being follows an approximate U-shape 
through life.  Yet in the eyes of some scholars this evidence remains controversial.  
The reason is that it relies on people’s answers to ‘happiness’ surveys.  The present 
paper explores a different approach.  It examines modern data on the use of 
antidepressant pills (as an implicit signal of mental distress) in 27 European nations. 
The regression-adjusted probability of using antidepressants reaches a peak in 
people’s late 40s.  This pattern -- one that does not rely on well-being survey answers 
-- is thus consistent with the claim that human beings experience a midlife low.   
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David G. Blanchflower   
Andrew J. Oswald   
1. Introduction   
For social scientists, antidepressants -- medications to alleviate mood disorders -- 
are an interesting modern commodity.  First, citizens in western society are now able to 
use such pills to ‘buy’ happiness, or at least less unhappiness, in a way that was not possible 
half a century ago.  Second, the taking of antidepressants is, by a kind of revealed 
preference, a potentially informative signal of mental distress, both about the person taking 
them and, more broadly, potentially about patterns in society at the aggregate level.  For 
these reasons, information on antidepressant consumption is studied in the current paper.1   
The paper explores, in particular, a new empirical justification for the claim that human 
well-being has a tendency to follow an approximate U-shape through life.  
In this study we provide evidence that:    
(i) One in thirteen Europeans have taken an antidepressant in the previous twelve 
months;   
(ii) The rates of antidepressant use are greatest in Portugal, Lithuania, France and 
the UK;   
(iii)  Adjusting for other characteristics, the probability of taking an antidepressant 
is greatest among those middle-aged, female, unemployed, poorly educated, 
and divorced or separated;     
                                                 
1 As in most work in social science, we will use data on reported actions (in this case the action will be the 
consumption of antidepressant pills) rather than literally observing those actions.  We will thus not use data 
on reported feelings, which is what has been done in most of the literature on U-shaped wellbeing. 
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(iv) A strong hill-shaped age pattern is found -- both for males and females and for 
the citizens of Western and Eastern Europe -- that peaks in people’s late 40s.    
(v) We argue that this pattern is consistent with, and thus might be seen as powerful 
and independent corroboration of, the claim in the well-being literature that 
happiness and mental health follow an approximate U-shape through life.2  The 
earlier, and more extreme, notion of a ‘midlife crisis’ goes back to Jaques 
(1965).   There has been much discussion, and some controversy, about the 
claim that there is a U-shape in wellbeing (for example, Blanchflower and 
Oswald 2008, 2009; Stone et al. 2010; Easterlin 2006; Glenn 2009; Frijters and 
Beatton 2012; Kassenboehmer and Haisken-DeNew 2012; Schwandt 2015; 
Van Landeghem 2008, 2012; Weiss et al. 2012; Cheng et al. 2016), and some 
social scientists continue to wonder whether ‘happiness’ answers should be 
treated as meaningful, although a formal test of validity, done in the 
economist’s spirit, has been suggested in Oswald and Wu (2010).    
One interpretation of the current paper is that the life cycle U-shape in human well-being -
- which emerges in a distinct and new way in data on antidepressant consumption -- 
increasingly calls for explanation and further research.  A smaller potential contribution of 
the paper is to provide statistically representative estimates for a large number of countries.  
Most previous work, such as Colman et al. (2006), Ohayon  and Lader (2002) and Pagura 
et al. (2011), has had to rely on single or small numbers of nations, or, like Knapp et al. 
(2007), on data on actual sales numbers of antidepressants which, while valuable, do not 
allow researchers to learn about the micro patterns of consumption by different individuals. 
                                                 
2 Many authors in the subjective well-being literature have replicated versions of the U-shape finding.  
Blanchflower and Oswald (2008) provide a historical list of such studies. 
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 This paper will not attempt to adjudicate in a fine-grained way between the concepts 
of unhappiness and depression.  That issue is an important one but it cannot be tackled with 
the data set used in this paper.  We will rely instead on the known fact that, as discussed in 
Blanchflower and Oswald (2008) and other sources, evidence for U-shaped well-being has 
been found by many research teams using both ‘happiness’ and ‘mental health’ data.  The 
research question tackled here is then an admittedly narrow but, we hope, not uninteresting 
one.  If data on antidepressant consumption are studied, is there any sign of empirical 
support for the idea of a midlife low (whether in happiness or in mental health)? 
2. Background 
 The backdrop to this study is a burgeoning interest among quantitative social 
scientists in the study of human well-being.  Today’s inhabitants of the industrialized 
nations lead what are perhaps the richest, longest, and most comfortable lives in human 
history.  As Offer (2007), Layard (2006, 2010) and others have argued, however, there are 
reasons to believe that not all is ideal in the industrialized countries.  Some citizens display 
signs of mental turmoil amid the prosperity of modern living (the data in McManus et al. 
2009 suggest that at any one time approximately 15% of people in the UK suffer from a 
mental disorder: their p.11) and Richard Easterlin’s seminal doubts (Easterlin 1974, 2003) 
remain pertinent.  Such concerns are mirrored in recent work by the 2009 Stiglitz 
Commission on the Measurement of Economic Performance and Social Progress: the 
authors argue that traditional ways of measuring social and economic progress are out-of-
date (www.stiglitz-sen-fitoussi.fr).  In the mental-health literature, too, there have been 
long-standing worries about the rates of clinical depression in modern society (Paykel 
2006).  A related literature, written partly by economists, has recently sprung up.  It 
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examines direct survey measures of well-being and mental health (and includes 
Theodossiou 1998; Frey and Stutzer 2002; Easterlin 2003; Blanchflower and Oswald 2004; 
Van Praag and Ferrer-I-Carbonell 2004; Graham 2005, 2008; Helliwell and Huang 2008; 
Clark et al. 2008; Deaton 2008; Dolan et al. 2008; Dolan and Kahneman 2008; Pacek and 
Radcliff 2008; Biswas-Diener et al. 2010; Oswald and Wu 2010; Powdthavee 2010; Green 
2010).  
The consumption of antidepressants has been little-studied in the economics 
literature.  Two exceptions are interesting papers by Kuhn, Lalive and Zweimuller (2009) 
and Ludwig, Marcotte and Norberg (2009).  The first of these shows that job loss caused 
by plant closure leads to greater antidepressant consumption; the second argues that an  
increase in sales of one particular antidepressant -- selective serotonin reuptake inhibitors 
(SSRIs) -- by 1 pill per capita produces a large reduction (of 5%) in a country’s suicide 
rate.  A further exception in the wider literature is Askitas and Zimmermann (2011), which 
examines data on the timing of people’s Google searches on antidepressants’ side-effects.  
An important empirical source for health-economics researchers in Europe is Knapp et al. 
(2007).  The authors document a near-doubling of antidepressant consumption (their Table 
7.5 on p. 154) in the ten years from 1990 to 2000.  Recent data from the OECD reveal a 
continuing upward trend: antidepressant consumption in daily-doses per thousand 
population rose from 32.4 in 2000 to 52.1 in 2007 (source: OECD 2009).        
Antidepressants are typically prescribed by physicians.  Hence it seems natural to 
begin by thinking of the probability, P, of taking an antidepressant as given by the joint 
probability of going to a doctor or psychiatric professional for help with a mental health 
problem, p, and being in a nation with a rate-of-prescribing probability, r.  Assume that p 
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is a function of personal characteristics, denoted by a vector x, and of national 
characteristics, denoted by a vector n.  Assume that the rate-of-prescribing is a national 
characteristic that for our purposes can be viewed as exogenously given (perhaps by 
cultural and historical norms).  Then we might write:   
P = p(x,n).r(n)   
= P(personal characteristics, country characteristics).   
We concentrate here on estimation of the reduced-form probability of antidepressant use, 
which is the function P(..).  As a referee has correctly pointed out, we are not able in the 
later analysis to observe completely objectively who took antidepressant pills and how 
many they took.  However, we are able to draw on cross-country survey information where 
individuals report this information.  
The main data set used in the analysis is the Eurobarometer survey #73.2, February-
March 2010.  The data cover the 27 countries listed in Table 1.  Unusually, this social-
science data set includes questions on the use of antidepressant pills.  The exact question 
(numbered QD5 on page 52 of the Eurobarometer questionnaire codebook) to which people 
responded was:    
“Have you taken any antidepressants in the last 12 months? Yes, regularly for a period of 
at least 4 weeks.  Yes, regularly for a period of less than 4 weeks. Yes, from time to time 
when I felt the need. No, not at all.”   
Table 1 provides a description of the raw patterns in the data set.  It gives the mean 
figure for each European country’s use of antidepressants.  For Europe as a whole, 
approximately 8% of people use antidepressants (within a single year).      
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In Austria, as one example, Table 1 shows that 91% of individuals said they had 
not taken any antidepressant in the previous twelve months; 4% answered “from time to 
time”; 1% said “regularly, for less than 4 weeks; 3% said “regularly, for more than 4 
weeks”.  Portugal stands out in the data as the nation with the highest rate of antidepressant 
consumption (in the sense of the proportion of people reporting such medication).  
Approximately 16% of Portugese citizens took antidepressants in the previous year, and 
9% did so for a long period (that is, more than 4 weeks).  Other countries with relatively 
high consumption, according to Table 1’s data, are France (9%, with 6% having done so 
for a long period), Lithuania (11%, with 3% having done so for a long period), Malta (10%, 
and 4%), and the UK (9%, and 7%).  Data on the total prescriptions within some of these 
nations are given for the year of 2002 in Rose (2007), within Knapp et al. (2007), as Table 
7.14 on their page 163.  Although many of the patterns are consistent with our Table 1, 
Belgium tops the Rose (2007) table.     
The numbers here in Table 1 are raw means of antidepressant use.  Later tables give 
regression-equation-adjusted rates.  At a referee’s suggestion, we also examined the 
country-level correlation between the happiness of nations and the use of antidepressants.  
Adjusting for country GDP-per-capita, that correlation is negative but not statistically 
significant; with just 27 country-level observations this is perhaps to be expected.    
It could be argued that people’s memories -- particularly in answering questions of 
this kind about lengths of time -- are likely to be imperfect.  The cell sizes here, for some 
categories of answer, are also small.  For these reasons, the paper’s later analysis chooses 
not to put a heavy weight on the exact number of weeks the individuals say that they 
consumed antidepressants.  Instead, its later focus is on the simpler distinction between 
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taking any antidepressants and taking none.  This is adopted because it seems likely that 
individuals will have an accurate appreciation for whether they were taking any pills at all.  
There is, necessarily, some loss of efficiency from this approach.  As a check, therefore, 
ordered logit equations have also been estimated.   
Bauer et al. (2008) and Sleath and Shih (2003) argue that prescribing norms vary 
by country -- for what appear to be cultural or sociological reasons -- so that it will be 
necessary in the later analysis to adjust for this fact by using country dummy variables.  
Consistent with such a view, Pagura et al. (2011) conclude that in the US almost one quarter 
of antidepressant prescriptions are to people without serious psychiatric conditions.   
The characteristics of those citizens in Europe who are most likely to use 
antidepressant medication can be seen in Table 2.  The table presents three regression 
equations, which are to be read vertically.  In each case, the dependent variable can be 
thought of as a measure of the probability of antidepressant use.  The sample size is 26,611 
individuals.  Although it is possible to include independent variables for many 
demographic and personal characteristics, a notable one is absent.  The data set does not 
contain an income variable.  Fortunately, a variable for age-left-school, denoted ALS in 
the tables, which is a strong correlate with earnings because it is a measure of the length of 
a person’s formal education, is available in the data set.   
The first column of Table 2 reports the estimates from an ordinary least squares 
(OLS) linear probability model in which the dependent variable uses data that are coded 1 
for any positive level of antidepressant use and 0 otherwise.  Column 2 of Table 2 estimates 
an otherwise equivalent Probit equation.  Column 3 is an Ordered Logit in which the 
dependent variable can take one of four values (No, Not at all,... Yes, regularly for a period 
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of at least four weeks).  The structure of the three equations, however, is in each case 
similar.   
Because of the cardinal nature of the estimator, column 1 of Table 2 is particularly 
straightforward to interpret.  First, a hump-shaped age profile in people’s use of 
antidepressants can be seen in the coefficients on the dummy variables from ‘Age 25-34’ 
up to ‘Age greater than or equal to 65’.  The base category in the regression equation is 
those people in the survey aged 15-24 years old.  In Table 2’s column 1, the largest 
coefficient on age is that for age band 45-54, at 0.0652.  Column 1 thus reveals that the 
probability of taking antidepressants rises gradually to reach a high point in the mid-life 
age band of 45-54.  It then falls back, by age 65 and above, to approximately the same 
probability that is implicitly found among the youngest group, age 15-24.  Experiments 
done with various functional forms -- available upon request -- suggest that the data are 
fairly well approximated by a simple quadratic equation. 3   
It might be wondered if the mid-life peak in antidepressant consumption found in 
Table 2 is merely a result of people in middle age tending disproportionately to have young 
children.  However, such an explanation is not supported empirically.  When a variable for 
the number of young children is included in the regression equation, it enters with a very 
small negative coefficient (the opposite of the sign that might perhaps have been expected) 
that is not statistically significantly different from zero.  Those specifications are available 
on request.  The size of the hump-shaped age pattern is not a negligible one.  At its peak, 
in mid-life, the hump-shape accounts in this specification for an extra approximately 6.5 
                                                 
3 This hill-shaped result appears to be a new one.  The closest we have been able to find in the existing 
literature is in the third column of Table 1 of Olfson and Marcus (2009) on US data.  The authors do not 
discuss the age profile.  However, the Olfson-Marcus estimation results are not exactly comparable to ours, 
because their regression equations hold constant the state of a person’s measured mental health. 
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percentage points in the probability of using antidepressants.  In other words, it nearly 
doubles the risk.  The age 45-54 coefficient of 0.0652 in column 1 of Table 2 is also slightly 
larger here than that on known stressful life events such as being unemployed or being 
divorced/separated.   
One way to depict the hump-shaped age profile is to do so graphically, as in Charts 
1 and 2.  To construct these graphs, we use a different and less parametrically restrictive 
estimation method than in the equations of the Tables.  Instead of six age-band variables, 
a separate dummy variable for (almost) every year of age from 15 up to 90 is now entered 
in the antidepressant-use regression equation.  There is one caveat; because sample sizes 
become small at higher ages, the exact approach was the following.   Above age 80, we 
grouped together the people aged 82 and 83 and plotted them on the chart as 81.5 years; 
similarly, we grouped those aged 84 and 85 and plotted them as 84.5; we grouped all 
individuals from 86-97 and plotted them as a weighted average assigned on the chart axis 
to age 88.  While simple, this method ensures that sample sizes for dots situated along the 
sparse part of the age range in the graphs are always based on at least a cell-size of 0.5% 
or N=200.  The same independent variables as before, with the exception of the banded 
age variables, are also included in the regression specifications in the two charts.     
Chart 1 gives a plot of the raw data; it is an unadjusted correlation (apart from 
country dummies).  By contrast, Chart 2’s scatter is derived from a full regression equation, 
where each of the dots in the chart corresponds to the probability at that particular age.  
This has the advantage that it produces in an approximately non-parametric way the same 
form of age profile as in Table 2’s columns.  There is strong evidence in Chart 2 of a peak 
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in antidepressant use in mid-life. 4  As previously in Table 2, the calculation holds constant 
other factors, so once again is to be viewed as a ceteris-paribus relationship.  In the raw 
unadjusted picture of Chart 1, the turn-down in antidepressant-use probability at higher 
ages exists, but is less clear in a simple scatter; the standard error bands -- not shown -- are 
large at higher ages.   
Other systematic influences are visible in the data.  Men, in Table 2, are less likely 
than women to take antidepressants.  The coefficient on Male in column 1 is -0.0372 with 
a t-statistic over 11.  Antidepressant use is highest among those living in the parental home 
(coefficient 0.0438), the unemployed (0.0520), the retired (0.0733), and those who are 
divorced or separated (0.0347).  Antidepressant use is low among students (-0.0645) and 
those married (-0.0254).  In column 1 of Table 2 there is a discernible monotonic gradient 
associated with years of education; ALS is the age at which a person left their formal 
education.  Those people who left school at greater than or equal to age 20 are almost 8 
percentage points less likely to be taking an antidepressant (the coefficient on ALS>=20 is 
-0.0781).  There are no statistically significant effects associated with being in the living-
together category of marital status or being widowed.      
   The coefficients on the country dummy variables are listed at the foot of Table 2.  
The base country, against which others are measured, is Belgium.  The positive coefficients 
are Austria, France, Malta, Portugal, the UK, Latvia, Lithuania, and Slovakia.  Of these, 
however, the only one in column 1 of Table 2 with a coefficient that is significantly 
different from zero at the 95% confidence level is Portugal.  These country-dummy 
                                                 
4 The intercept on the y-axis in the charts has been normalized by expressing all the plotted probabilities 
relative to an age-15 probability set to zero.  In the raw data, the mean in the probability of antidepressant 
use in Europe is approximately 0.08.   
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coefficients are not small.  They vary, in column 1 of Table 2, from 0.0767 for Portugal to 
-0.0522 in Greece.  This implies a spread of 13 percentage points in the likelihood of 
antidepressant use.   
Columns 2 and 3 of Table 2 reinforce the conclusions from the simple OLS linear-
probability estimator.  There are only marginal differences, when compared to column 1, 
in variables’ qualitative influence or levels of statistical significance.   
One interesting and potentially important distinction is that between Western 
Europe and Eastern Europe.  The transition countries have lower levels of Gross Domestic 
Product and, especially when compared to the western countries, may have rather different 
medical-prescribing practices.  Table 3 therefore calculates results separately for the set of 
nations from Western Europe (including East Germany, within the nation Germany).  The 
econometric results -- from now on, for simplicity, only OLS linear probability models are 
presented -- are similar to those in the full sample.  However, the coefficient on being 
unemployed is now slightly larger (at 0.0713 in column 1 of Table 3) and the education 
gradient becomes steeper (the coefficient on ALS over 20 is now -0.0980).   
Table 3 continues to find a well-defined hump shape in the effect of age on the 
probability of consuming antidepressants.  Compared to the young and the old, people in 
midlife in Western Europe have an approximately doubled probability of antidepressant 
use.   
The main findings are broadly robust across the genders.  Columns 2 and 3 of Table 
3 compare the male sub-sample to the female sub-sample.  Perhaps the most interesting 
difference in the size of coefficients is for the ALS age-left-school variable.  Men in 
Western Europe have a more pronounced education gradient in the risk of antidepressant 
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medication.  At a low, in column 2, the coefficient is -0.1605 for males compared to -
0.0653 among females.  In this correlational sense, it could be said that low qualifications 
appear to be particularly a danger for the mental health of men.  It is also noticeable that 
the coefficient on the Portugal dummy variable is considerably greater for women.   
Eastern Europe is examined on its own in Table 4.  There are separate regression 
equations for the full sample, the males, and the females.     
A hump-shaped age pattern is again visible.  Both for females and males, 
antidepressant use is at its greatest in people’s midlife.  The size of the effect at age 45-54 
is similar (0.0597 for men and 0.0470 for women); the null of equality of these coefficients 
in Table 4 cannot be rejected.  In Table 4, however, there is little sign of an education 
gradient.     
In most countries, part of the process of taking antidepressants is first to visit a 
doctor or health professional.  That information is available in the data set.  Therefore Table 
5 estimates a different form of equation (the p(..) functional form discussed earlier).  Here 
the dependent variable is no longer antidepressant consumption but rather a variable for 
consulting a mental-health specialist.  The exact survey question is:    
“In the last 12 months, did you seek help from a professional because of a psychological 
or emotional problem. Yes or no.”     
The mean of this in the data is 11%, so in 2010 approximately one in nine 
Europeans consulted a professional about mental health problems.   
Table 5 reports zero-one OLS equations for the probability of consulting a mental-
health professional.  To allow for consistency of interpretation with earlier regressions, the 
set of independent variables is the same as in Tables 2 to 4.  For the full sample of column 
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1 of Table 5 there continues to be evidence of a well-determined age pattern.  The 
probability of seeking help for a psychological or emotional problem reaches its turning 
point -- adjusting for other factors -- in the 45-54 age band.  Males, students, the married, 
and those with high levels of education are less likely to see a mental-health professional.  
Those living at home, the unemployed, the retired, and the divorced or separated are more 
likely to do so.  The t-statistics on the relevant coefficients are typically large in column 1 
of Table 5.   
Results for the West and East are given separately in columns 2 and 3 of Table 5.  
Particularly for Eastern Europe, many of the coefficients now become fairly poorly 
defined.  For example, an age pattern is now barely discernible, with large standard errors.  
The only variables in the Eastern Europe equations with coefficients that are statistically 
significantly different from zero are Male, Student, and Retired.  For Western Europe, 
nevertheless, the existence of a hump-shaped age profile is still clear in the data.  The 
largest coefficient is 0.0321 (t-statistic 3.46) on age-group 45 to 54.  However, for Western 
Europe there is little sign of an age-left-school effect on the probability of consulting a 
mental-health professional.   
Despite the different dependent variable, the country dummies in Table 5 therefore 
produce a similar life-cycle pattern to that found in the earlier antidepressant-use equations.  
The largest positive coefficient in the full sample of column 1 is for Romania at 0.1395 
with a t-statistic of 10.08.  Slovakia and Portugal also have large coefficients.  The smallest 
coefficients in Table 5 are found for Bulgaria, Cyprus and Greece. 
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As a final formal check, Table 6 re-estimates the model using a probit equation, 
and Table 7 gives equivalent results for a variant question (with details explained at the 
foot of Table 7).  The same hump-shaped pattern tends to emerge once again.     
3. Potential Issues  
On the hill-shaped distribution with respect to age, it is possible to think of various 
potential objections (we thank, in particular, Dr Ian Colman for discussions on these).  Here 
we list some, with possible responses.   
(i) Prescribing patterns may differ by country and by age: one possibility is that 
people who are employed may be more likely to be treated (presumably because 
physicians want to help people get back to work). In principle, that could create 
a hill-shaped distribution.   
Our econometric estimates do control for country dummies, and also for whether the person 
is employed.  Thus the hill-shape cannot be being generated merely by intercept differences 
in national medical practices.  If it were true that physicians felt they should encourage 
workers back into the workplace, it is difficult to see why the hill-shape would be so 
noticeably peaked in midlife.  It might be expected, instead, that the probability would run 
fairly flat from people’s early 20s to their mid-60s (the usual working-career length).   
(ii) This study is unable to follow the same individuals longitudinally through time 
(as Colman et al. 2006 can), which means that the age variable may be 
correlated with some form of birth-cohort effect.   
This is a justifiable concern and one common to all studies of our type.  Nevertheless, in 
this case, a multi-country cross-sectional design has one advantage.  Through the decades, 
it may indeed be that antidepressant-prescribing norms by Europe’s physicians have 
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changed (in a way that affects the link between underlying mental distress and observed 
antidepressant consumption).  Yet that kind of potential bias is not present in the present 
study; our data come from the same year and the equations allow for different intercept 
shifters in each nation.  Moreover, it is known that the U-shape in wellbeing through the 
life course is not itself because of cohort effects (as shown in a specific test in Blanchflower 
and Oswald 2008).   
(iii) As people age, the presentation of depression might change, such that older 
individuals become more likely to present with somatic complaints rather than 
mood complaints. Physicians may be more likely to treat the somatic symptoms 
without recognizing an episode of depression.   
This is a possible interpretation.  However, it is a particular theory, it might be said, of the 
hill-shape, rather than a criticism of the results themselves.   
(iv) Treatment-seeking may differ by age.  It could be that younger adults are less 
likely to seek treatment than middle-aged adults.     
This is possible, and unfortunately is not easily tested.  It cannot, however, account for the 
drop-off in antidepressant use in older age groups (who presumably are well-informed, 
when compared to the young, about the concept of antidepressant treatment).   
(v) The hump-shape in antidepressant consumption may somehow be reflecting not 
ageing per se, but instead a midlife threat of, or insecurity from, unemployment. 
We checked this by including an extra set of interaction dummies between being 
unemployed and a series of age bands.  The coefficients were statistically insignificantly 
different from zero, and the hill-shape in age was unaffected. 
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(vi) There could be a form of ‘survivor’ effect -- severe depression is associated 
with suicide and other chronic diseases that lead to death. The remaining 
population is therefore healthier and less likely to need antidepressants.   
Such an argument is qualitatively a good one; presumably the mechanism must play some 
role.  However, the annual risk of suicide per-person in an industrialized country is 
approximately 1 in 10,000, so quantitatively it is difficult to see how a compositional 
suicide-survivor theory could explain a large proportion of the observed hill-shape in 
antidepressant use.  The turning point in the hill-shape occurs long before many deaths 
have occurred.  
 when compared to the young, about the concept of antidepressant treatment).   
(v) There could be a form of ‘survivor’ effect -- severe depression is associated with 
suicide and other chronic diseases that lead to death. The remaining population is therefore 
healthier and less likely to need antidepressants. 
4. Conclusions   
This paper studies the patterns of antidepressant use in Europe.  It draws three main 
conclusions.    
First, a hill-shaped age pattern is found in these modern European data (after 
adjustment for a standard set of covariates).  The concave shape is illustrated in Chart 2.  
People in mid-life are approximately twice as likely to be taking antidepressants as 
individuals with the same characteristics who are under the age of 25 or over the age of 65.  
As statistical checks in the paper reveal, this finding seems to be robust to a large number 
of sub-sample re-estimations, including a division into males and females or into West and 
East.  Rather robustly, the regression-adjusted probability of using an antidepressant attains 
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a maximum in approximately people’s late 40s.  This seems to suggest that mental distress 
occurs particularly strongly in midlife.  Such a pattern is consistent with recent claims in 
the well-being literature that happiness and mental health follow a U-shape through life.  If 
this paper’s evidence is viewed as a valuable corroboration of the U-shape, it suggests that 
the need for a conceptual explanation of that quadratic lifetime path of human well-being 
remains a pressing one.  
Second, the probability of taking antidepressants is also greater among those who 
are female, unemployed, poorly educated, and divorced or separated.  These patterns may 
repay further study by social scientists. 
Third, despite the security and wealth of modern living, 1 in 13 European citizens 
used antidepressants in the year 2010, and rates of consumption are notably high in 
Portugal, Lithuania, France and the UK.  One interpretation of such findings is that they 
support the broader societal concerns of the Stiglitz Commission. 
  
18 
 
  
Table 1.  The Proportion of Europeans Who Took Antidepressants    
Over the Previous 12 months (%)   
   
                                               Not at all         Time to time       Regularly          Regularly    
                                                                                                 <4 weeks         >=4 weeks   
Austria  91% 4% 1% 3%   
Belgium      91 3 1 5   
Bulgaria  96 3 0 1   
Cyprus  96 2 1 2   
Czech Republic  95 3 0 1   
Denmark      93 1 1 5   
Estonia  93 2 0 4   
Finland  94 1 1 4   
France  91 3 1 6   
Germany  95 1 1 3   
Greece  97 1 0 1   
Hungary  93 3 1 3   
Ireland  95 2 1 3   
Italy  94 4 1 1   
Latvia  92 6 1 2   
Lithuania  89 6 1 3   
Luxembourg      94 1 1 3   
Malta  90 4 1 4   
Netherlands  94 1 0 4   
Poland  94 3 1 2   
Portugal  84 5 2 9   
Romania  93 5 1 1   
Slovakia  91 6 1 2   
Slovenia  92 5 0 2   
Spain  92 2 1 5   
Sweden  92 1 0 7   
UK 91 1 1 7   
   
Source: Own calculations using Eurobarometer #73.2, February-March 2010.  Sample 
size: Approximately 1000 randomly sampled citizens per nation.     
   
Question wording.  Have you taken any antidepressants in the last 12 months? No, not at 
all; Yes, from time to time when you felt the need to; Yes, regularly for a period of less 
than four weeks; Yes, regularly for a period of at least four weeks?   
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Table 2.  Regression Equations for the Probability of Taking Anti-depressants in 
Data on 27 Nations   
                                                      OLS                 Probit                    Ordered logit     
Age 25-34  .0289 (3.68)   .0374 (3.81)  .5751 (3.76)   
Age 35-44  .0501 (6.06)   .0666 (6.14)  .9361 (6.04)   
Age 45-54  .0652 (7.81)   .0858 (7.56)  1.1396 (7.42)   
Age 55-64  .0450 (5.08)   .0618 (5.51)  .8507 (5.27)   
Age ≥65  .0037 (0.37)     .0222 (2.10)  .3881 (2.27)   
Male  -.0372 (11.12)  -.0363 (11.63) -.6099 (11.42)   
Home   .0438 (6.71)   .0468 (6.89)  .6558 (7.28)   
Student  -.0645 (2.53)  -.0325 (2.05) -.5851 (1.91)   
Unemployed   .0520 (8.52)   .0587 (8.95)  .7834 (9.40)   
Retired   .0733 (12.18)   .0695 (11.73)  .9900 (11.86)   
Married  -.0254 (4.99)  -.0228 (4.83) -.3932 (5.10)   
Living together  -.0068 (1.05)  -.0047 (0.78) -.1204 (1.14)   
Divorced/separated   .0347 (4.66)   .0231 (3.40)  .3092 (3.22)   
Widowed   .0101 (1.32)   .0025 (0.39)  .0051 (0.05)   
ALS<16  -.0611 (2.53)  -.0285 (1.87) -.4615 (1.84)   
ALS 16-19   -.0706 (2.93)  -.0381 (2.27) -.5647 (2.25)   
ALS >=20   -.0781 (3.23)  -.0408 (2.67) -.6908 (2.74)   
Austria   .0012 (0.11)  .0021 (0.22)   .0184 (0.11)   
Cyprus  -.0352 (2.49) -.0302 (2.65) -.6592 (2.60)   
Denmark  -.0126 (1.09)  -.0108 (1.12) -.1385 (0.81)   
Finland  -.0310 (2.69) -.0242 (2.70) -.4604 (2.56)   
France   .0057 (0.50)  .0039 (0.39)  .0997 (0.64)   
Germany  -.0422 (4.04)  -.0331 (4.26) -.6945 (4.15)   
Greece  -.0522 (4.51)  -.0441 (5.23) -1.0909 (4.97)   
Ireland  -.0280 (2.42) -.0232 (2.53)  -.4438 (2.45)   
Italy  -.0161 (1.40) -.0134 (1.40) -.2608 (1.50)   
Luxembourg  -.0265 (1.88) -.0194 (1.70) -.3783 (1.70)   
Malta   .0267 (1.87)  .0187 (1.43)  .2891 (1.56)   
Netherlands  -.0166 (1.45) -.0154 (1.61)  -.2367 (1.34)   
Portugal   .0767 (6.56)  .0625 (5.10)  .7622 (5.19)   
Spain  -.0045 (0.39)  -.0040 (0.41) -.0213 (0.13)   
Sweden  -.0100 (0.87) -.0060 (0.62)     -.0920 (0.54)   
UK   .0035 (0.32)  .0013 (0.15)  .0836 (0.56)   
Bulgaria  -.0443 (3.83)  -.0348 (4.03) -.7839 (4.01)   
Czech Republic  -.0318 (2.77)  -.0257 (2.84) -.5482 (2.98)   
Estonia  -.0196 (1.70) -.0160 (1.73) -.2768 (1.63)   
Hungary  -.0225 (1.96) -.0192 (2.13) -.3504 (2.10)   
Latvia   .0027 (0.24)  .0016 (0.16)   -.0099 (0.06)   
Lithuania   .0180 (1.56)  .0120 (1.16)  .1670 (1.08)   
Poland  -.0251 (2.18) -.0202 (2.24) -.3772 (2.21)   
Romania  -.0141 (1.23) -.0112 (1.16) -.2356 (1.38)   
Slovakia   .0081 (0.71)  .0060 (0.59)  .0712 (0.44)   
Slovenia  -.0010 (0.09) -.0019 (0.20) -.0544 (0.34)   
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Constant/cut1 .1218    2.5652   
Cut2     3.1669   
Cut3     3.3706   
     
Adjusted R2/Pseudo R2 .0369 .0712 .0568   
N 26,611 26,611 26,611   
   
Source: Eurobarometer #73.2, February-March 2010.   
 
t-statistics are given in parentheses.    
   
Notes. Base (i.e. reference) categories: age 15-24; Belgium; employed; no fulltime 
education; and single.  ALS is age left schooling.  Column 1 is estimated as a linear 
probability ordinary-least-squares model where the dependent variable is 1 for having 
taken any level of antidepressants and zero otherwise.  Column 2 is estimated as a dprobit 
using Stata.  Column 3 is estimated as an ordered logit using all four possible survey 
answers.   
   
If a variable for the number of young children is included in these regression equations, 
its coefficient is small and statistically insignificantly different from zero.   
   
Question wording.  Have you taken any antidepressants in the last 12 months? No, not at all; Yes, from 
time to time when you felt the need to; Yes, regularly for a period of less than four weeks; Yes, regularly for 
a period of at least four weeks?   In columns 1 and 2 the dependent variable is set to zero if ‘no, not at all”, 
zero if otherwise. In column 3 ‘no, not at all=1; from time to time=2 and so on.
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Table 3.  Regression Equations for the Probability of Taking Anti-depressants in Western 
Europe (Estimated with a linear probability OLS model)   
   
   
                                                  Full Sample        Male Female   
Age 25-34  .0333 (3.34)  .0336 (2.72)  .0344 (2.25)   
Age 35-44   .0583 (5.56)  .0600 (4.59)  .0561 (3.50)   
Age 45-54   .0692 (6.54)  .0522 (3.98)  .0819 (5.04)   
Age 55-64  .0461 (4.14)  .0173 (1.23)  .0656 (3.87)   
Age ≥65 -.0009 (0.08) -.0235 (1.47)  .0080 (0.43)   
Male  -.0293 (6.83)       
Home   .0581 (7.46)  .1308 (4.45)  .0513 (5.34)   
Student  -.0763 (2.52) -.1603 (3.76) -.0238 (0.56)   
Unemployed   .0713 (8.48)  .0828 (8.09)  .0587 (4.46)   
Retired    .0655 (8.65)  .0817 (8.52)  .0586 (5.03)   
Married  -.0237 (3.80) -.0213 (2.81) -.0246 (2.49)   
Living together   -.0108 (1.31)  .0000 (0.01) -.0214 (1.64)   
Divorced/separated   .0481 (5.16)  .0320 (2.62)  .0589 (4.27)   
Widowed    .0141 (1.45)  .0022 (0.16)  .0188 (1.36)   
ALS<16  -.0754 (2.66) -.1499 (3.70) -.0316 (0.81)   
ALS 16-19   -.0878 (3.09) -.1614 (3.98) -.0436 (1.11)   
ALS >=20   -.0980 (3.45) -.1605 (3.96) -.0653 (1.65)   
Austria   .0018 (0.16)  .0232 (1.61) -.0171 (0.97)   
Cyprus  -.0377 (2.65)  .0016 (0.10) -.0769 (3.48)   
Denmark  -.0092 (0.79) -.0066 (0.46) -.0117 (0.65)   
Finland  -.0263 (2.27) -.0211 (1.49)  -.0312 (1.73)   
France   .0076 (0.67)  .0075 (0.53)  .0074 (0.43)   
Germany  -.0417 (3.97) -.0237 (1.85) -.0599 (3.67)   
Greece  -.0540 (4.62) -.0346 (2.42) -.0739 (4.07)   
Ireland  -.0311 (2.66) -.0200 (1.37) -.0410 (2.31)   
Italy  -.0165 (1.43) -.0145 (1.01) -.0191 (1.08)   
Luxembourg  -.0254 (1.80)   .0042 (0.24)  -.0508 (2.35)   
Malta   .0236 (1.64)  .0242 (1.28) .0211 (0.99)   
Netherlands  -.0145 (1.26) -.0092 (0.66) -.0217 (1.21)   
Portugal   .0757 (6.39)  .0387 (2.64)  .1054 (5.80)   
Spain  -.0087 (0.74) -.0179 (1.23) -.0019 (0.11)   
Sweden  -.0047 (0.41)  .0033 (0.23) -.0114 (0.63)   
UK   .0054 (0.50)  .0068 (0.51)  .0033 (0.20)   
Constant  .0864 .1711 .0920   
    
Adjusted R2/Pseudo R2 .0399 .0343 .0392   
N 16,512 7713 8799   
   
Source: Eurobarometer #73.2, February-March 2010.  t-statistics are given in parentheses.      
Notes: see Table 2.
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Table 4.  Regression Equations for the Probability of Taking Anti-depressants in Eastern 
Europe (Estimated with a linear probability OLS model)   
   
   
                                             Full Sample  Males                          Females      
Age 25-34  .0234 (1.83)  .0335 (2.39)  .0122 (0.58)   
Age 35-44   .0352 (2.60)  .0391 (2.60)  .0286 (1.31)   
Age 45-54   .0552 (4.02)  .0597 (3.90)  .0470 (2.11)   
Age 55-64  .0340 (2.28)  .0281 (1.68)  .0391 (1.62)   
Age ≥65  .0095 (0.56) -.0208 (1.05)  .0303 (1.13)   
Male  -.0472 (8.80)      
Home   .0061 (0.49)  .0836 (2.78) -.0025 (0.16)   
Student  -.0394 (0.83) -.1750 (1.73) -.0192 (0.32)   
Unemployed   .0333 (3.75)  .0225 (2.26)  .0484 (3.38)   
Retired   .0871 (8.56)  .1146 (9.67)  .0653 (4.12)   
Married  -.0263 (2.98) -.0305 (3.04) -.0155 (1.10)   
Living together   .0010 (0.10)  .0009 (0.09)   .0038 (0.21)   
Divorced/separated   .0138 (1.11)  .0015 (0.10)  .0267 (1.46)   
Widowed    .0000 (0.01) -.0184 (1.00)  .0088 (0.50)   
ALS<16  -.0317 (0.68) -.1970 (1.95)  .0078 (0.14)   
ALS 16-19  -.0347 (0.76) -.1798 (1.79) -.0059 (0.11)   
ALS >=20  -.0386 (0.84) -.1829 (1.82)  -.0118 (0.21)   
Bulgaria  -.0496 (4.24) -.0230 (1.65) -.0692 (3.87)   
Czech Republic  -.0365 (3.12) -.0050 (0.37) -.0620 (3.41)   
Estonia  -.0257 (2.20)  .0051 (0.37) -.0485 (2.75)   
Hungary  -.0286 (2.45) -.0164 (1.21) -.0394 (2.18)   
Lithuania   .0166 (1.43)  .0053 (0.40)  .0285 (1.57)   
Poland   -.0298 (2.53) -.0087 (0.63)  -.0449 (2.49)   
Romania  -.0170 (1.46)  -.0063 (0.48) -.0264 (1.41)   
Slovakia    .0040 (0.35)  .0056 (0.42)   .0040 (0.23)   
Slovenia  -.0100 (0.86)  .0061 (0.45) -.0237 (1.33)   
Constant/cut1  .1038  .1878   .0831   
     
Adjusted R2/Pseudo R2 .0372 .0352 .0269   
N                                        10,099                           4,478                            5,621   
   
Source: Eurobarometer #73.2, February-March 2010.  t-statistics are given in parentheses.    
Notes: see Table 2.  Excluded category – Latvia.   
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Table 5.  Regression Equations for the Probability of Seeing a Mental-Health Professional 
(Estimated with a linear probability OLS model)   
   
                                    Full Sample                Western Europe          Eastern Europe   
Age 25-34  .0084 (0.88)   .0179 (2.05) -.0130 (0.82)   
Age 35-44   .0153 (1.53)   .0285 (3.11) -.0098 (0.58)   
Age 45-54    .0310 (3.07)   .0321 (3.46)  .0035 (0.21)   
Age 55-64  .0259 (2.41)   .0024 (0.25)  .0103 (0.56)   
Age ≥65  .0192 (1.59)  -.0310 (2.83)  .0395 (1.87)   
Male  -.0304 (7.49)  -.0198 (5.28) -.0303 (4.53)   
Home   .0296 (3.74)   .0303 (4.45) -.0023 (0.15)   
Student  -.1699 (5.50)  -.0320 (1.21) -.1218 (2.04)   
Unemployed   .0290 (3.93)   .0506 (6.87)  .0122 (1.11)   
Retired   .0438 (6.00)   .0437 (6.57)  .0496(3.91)   
Married  -.0170 (2.75)  -.0328 (6.00)  .0021 (0.19)   
Living together  -.0109 (1.37)   -.0127 (1.76) -.0015 (0.11)   
Divorced/separated   .0293 (3.24)    .0263 (3.22)  .0222 (1.43)   
Widowed    .0056 (0.60)  -.0109 (1.29)  .0102 (0.65)   
ALS<16    -.1278 (4.36)  -.0433 (1.75) -.0732 (1.26)   
ALS 16-19   -.1535 (5.25)  -.0457 (1.84) -.1025 (1.78)   
ALS >=20    -.1622 (5.54)  -.0293 (1.18) -.1071 (1.86)   
Austria   -.0037 (0.27)  -.0290 (2.86)    
Cyprus  -.0757 (4.40)  .0087 (0.70)    
Denmark  -.0090 (0.64)  -.0082 (0.80)    
Finland  -.0515 (3.68)  -.0308 (3.03)    
France  -.0068 (0.49)   .0018 (0.18)    
Germany  -.0473 (3.75)  -.0237 (2.59)    
Greece    -.0863 (6.13)  -.0302 (2.95)    
Ireland  -.0168 (1.20)  -.0297 (2.92)    
Italy   -.0249 (1.79)   .0087 (0.86)    
Luxembourg     -.0503 (2.94)   -.0069 (0.56)    
Malta  -.0166 (0.96) -.0242 (1.92)     
Netherlands  -.0225 (1.61)     .0271 (2.68)    
Portugal   .0323 (2.28)  -.0125 (1.21)    
Spain  -.0230 (1.63)   -.0081 (0.79)    
Sweden  -.0336 (2.40)  -.0205 (2.01)    
UK  -.0242 (1.85)  -.0469 (0.70)    
Bulgaria  -.0872 (6.24)  -.0894 (6.13)   
Czech Republic  -.0209 (1.50)    -.0206 (1.41)   
Estonia  -.0132 (0.95)   -.0128 (0.88)   
Hungary  -.0445 (3.20)   -.0457 (3.13)   
Latvia  -.0040 (0.29)      
Lithuania   .0036 (0.26)   .0077 (0.53)   
Poland  -.0676 (4.82)  -.0681 (4.64)   
Romania   .1395 (10.08)    .1390 (9.58)   
Slovakia   .0513 (3.68)   .0534 (3.67)   
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Slovenia  -.0421 (3.01)   -.0463 (3.19)   
Constant  .2717 .1118  .2208   
     
Adjusted R2/Pseudo 
R2 .0326 .0220 .0515   
N                                  26,800                          16,618                       10,182   
   
Source: Eurobarometer #73.2, February-March 2010.  t-statistics are given in parentheses.     
Notes: Base (i.e. reference) categories: Belgium in columns 1 and 2, and Latvia in column 3.     
 
Question wording: In the last 12 months, did you seek help from a professional because of a psychological or 
emotional problem?
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Table 6.  Regression Equations for the Probability of Seeing a Mental-Health Professional 
(dprobit)   
  
                                                Psychiatrist                Psychologist              Other Psych.  
                                   Professionals 
Age 25-34   .0112 (2.69)  .0015 (0.57)  .0102 (2.00) 
Age 35-44    .0187 (3.93)  .0059 (1.92)  .0247 (4.18) 
Age 45-54    .0173 (3.62)   .0026 (0.90)  .0204 (3.45) 
Age 55-64   .0043 (1.03) -.0055 (2.10) -.0005 (0.10) 
Age ≥65  -.0097 (2.82) -.0129 (5.13) -.0240 (4.97) 
Male    -.0034 (2.48) -.0049 (4.05) -.0100 (4.91) 
Home    .0102 (3.43)  .0026 (1.16)  .0097 (2.42) 
Student   -.0011 (0.21) -.0010 (0.26)  .0027 (0.36) 
Unemployed    .0109 (3.43)  .0122 (4.42)  .0218 (4.74) 
Retired    .0322 (10.56)  .0149 (5.90)  .0458 (10.82) 
Married   -.0081 (3.35) -.0051 (2.45) -.0138 (3.81) 
Remarried  -.0068 (1.61) -.0017 (0.39) -.0072 (1.03) 
Living together   -.0048 (1.69) -.0004 (0.18)  .0016 (0.38) 
Previously lived together   .0071 (1.73)  .0087 (2.46)  .0197 (3.18) 
Divorced   .0012 (0.40)  .0091 (2.75)  .0125 (2.39) 
Separated    .0149 (2.49)  .0203 (3.48)   .0373 (4.01) 
Widowed  -.0043 (1.54) -.0007 (0.27) -.0055 (1.22) 
Mar9    .0041 (0.55) -.0039 (0.72) -.0100 (1.02) 
Mar10  -.0054 (0.45)  .0049 (0.38)  .0132 (0.64) 
ALS<16   .0000 (0.00) -.0005 (0.18) -.0005 (0.09) 
ALS 16-19  -.0009 (0.26) -.0041 (1.25) -.0038 (0.65) 
ALS >=20  -.0021 (0.55) -.0023 (0.71)  .0009 (0.16) 
Austria  -.0090 (2.60) -.0006 (0.14) -.0138 (2.38) 
Cyprus  -.0086 (1.85)  .0071 (1.11)  -.0087 (1.09) 
Denmark   -.0092 (2.62)  .0190 (3.09) -.0022 (0.35) 
Finland   -.0026 (0.67)  .0064 (1.25) -.0021 (0.33) 
France   .0003 (0.08)  .0040 (0.84)  .0063 (0.93) 
Germany  -.0081 (2.55)  .0064 (1.37) -.0049 (0.86) 
Greece     -.0018 (0.44)  .0039 (0.80) -.0018 (0.27) 
Ireland  -.0127 (3.77)  -.0054 (1.33)  -.0182 (3.18) 
Italy  -.0120 (3.65) -.0003 (0.08) -.0162 (2.86) 
Luxembourg    -.0005 (0.11) -.0013 (0.23) -.0019 (0.24) 
Malta  -.0067 (1.45) -.0026 (0.48) -.0140 (1.82) 
Netherlands  -.0014 (0.37)  .0280 (4.15)   .0210 (2.81) 
Portugal   .0062 (1.31)  .0103 (1.86)   .0120 (1.61) 
Spain  -.0034 (0.85)  .0234 (3.53)  .0063 (0.88) 
Sweden  -.0058 (1.53)  .0159 (2.66)  .0021 (0.32) 
UK   -.0109 (3.58) -.0052 (1.40) -.0211 (4.21) 
Bulgaria  -.0105 (3.10) -.0090 (2.37) -.0243 (4.52) 
Czech Republic  -.0023 (0.59) -.0010 (0.24) -.0068 (1.09) 
Estonia  -.0021 (0.52) -.0039 (0.95) -.0095 (1.57) 
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Hungary  -.0006 (0.16) -.0022 (0.52)  -.0057 (0.92) 
Latvia  -.0117 (3.64) -.0025 (0.62) -.0173 (3.17) 
Lithuania  -.0015 (0.37) -.0007 (0.16) -.0040 (0.64) 
Poland  -.0052 (1.44)  .0020 (0.43) -.0087 (1.45) 
Romania  -.0124 (3.86) -.0090 (2.38) -.0245 (4.63) 
Slovakia  -.0068 (1.86) -.0066 (1.66) -.0152 (2.61) 
Slovenia  -.0061 (1.65) -.0031 (0.74) -.0127 (2.15) 
Turkey -.0053 (1.35)  .0067 (1.27) -.0026 (0.39) 
Croatia  .0015 (0.36) -.0041 (1.03) -.0078 (1.27) 
Turkish Cyprus  .0008 (0.16)  .0289 (3.57)    .0112 (1.24) 
   
Pseudo R2  .0687 .0816 .0613 
N 29248  29248 29248 
 
Source: Eurobarometer #64.4 December 2005-January 2006. t-statistics are given in parentheses.  
Base categories: employed; Belgium; and age<25. 
Column 3 includes psychoanalysts and psychotherapists. 
 
Question wording: In the last 12 months, did you seek help from a professional in respect of a psychological or 
emotional health problem? (IF YES), Indicate who in the following list…
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Table 7.  Regression Equations for the Probability of Having Mental-Health Problems 
(dprobit)   
  
                                               Psychotherapy             Taken drugs        Admitted to hospital 
Age 25-34    .0095 (1.76)  .0222 (2.49) -.0009 (0.35) 
Age 35-44     .0237 (3.83)  .0562 (5.59)     .0003 (0.11) 
Age 45-54     .0242 (3.82)  .0766 (7.17)  .0007 (0.25) 
Age 55-64    .0030 (0.53)  .0594 (5.55) -.0040 (1.48) 
Age ≥65   -.0196 (3.78)  .0187 (1.85)  -.0087 (3.29) 
Male     -.0084 (3.99) -.0320 (9.99)  .0026 (2.11) 
Home     .0145 (3.45)  .0421 (6.64)  .0132 (4.66) 
Student    -.0065 (0.95) -.0144 (1.26)   -.0080 (2.77) 
Unemployed     .0352 (6.94)  .0533 (7.20)  .0119 (3.91) 
Retired     .0509 (11.74)  .0782 (13.55)  .0244 (9.05) 
Married    -.0068 (1.80) -.0164 (2.73) -.0011 (0.50) 
Remarried    .0077 (0.92)  .0052 (0.44)  .0096 (1.71) 
Living together     .0019 (0.39) -.0031 (0.41) -.0004 (0.15) 
Previously lived together    .0291 (4.16)  .0451 (4.31)   .0121 (2.77) 
Divorced   .0162 (2.82)    .0311 (3.61)  .0094 (2.55) 
Separated    .0421 (4.20)  .0599 (4.21)  .0191 (3.08) 
Widowed    .0013 (0.27)  .0070 (0.95)  .0043 (1.38) 
Mar9    .0105 (0.91) -.0028 (0.15)  .0144 (1.91) 
Mar10   .0384 (1.68)  .0238 (0.79)   .0129 (1.02) 
ALS<16   -.0062 (1.21)  .0017 (0.22) -.0039 (1.60) 
ALS 16-19  -.0119 (2.24) -.0097 (1.19) -.0074 (2.84) 
ALS >=20  -.0076 (1.44) -.0083 (1.00)   -.0064 (2.62) 
Austria  -.0036 (0.52)  .0121 (1.08) -.0073 (3.56) 
Cyprus  -.0081 (0.93) -.0534 (4.53) -.0090 (3.38) 
Denmark  -.0001 (0.02) -.0135 (1.31)  -.0096 (4.96) 
Finland    .0113 (1.47) -.0137 (1.34) -.0096 (4.92) 
France    .0054 (0.74)  .0049 (0.45)   -.0084 (4.27) 
Germany  -.0096 (1.61) -.0149 (1.61)  -.0098 (5.74) 
Greece    -.0087 (1.29) -.0328 (3.40)  -.0101 (5.14) 
Ireland   .0016 (0.22) -.0085 (0.79) -.0083 (3.94) 
Italy  -.0111 (1.70) -.0263 (2.63) -.0083 (4.03) 
Luxembourg   -.0063 (0.74)  .0048 (0.37) -.0073 (2.79) 
Malta   .0014 (0.16)  -.0234 (1.91) -.0080 (3.04) 
Netherlands   .0191 (2.41) -.0028 (0.28) -.0091 (4.80) 
Portugal   .0096 (1.24)  .0194 (1.68)  -.0094 (5.05) 
Spain   .0139 (1.71) -.0089 (0.84) -.0079 (3.80) 
Sweden   .0089 (1.17) -.0065 (0.61) -.0105 (5.22) 
UK    -.0107 (1.76) -.0060 (0.61) -.0088 (4.87) 
Bulgaria  -.0177 (2.88) -.0228 (2.28) -.0104 (5.50) 
Czech Republic  -.0125 (1.94)  -.0140 (1.36) -.0100 (5.16) 
Estonia  -.0148 (2.37)  .0129 (1.16)   -.0105 (5.51) 
Hungary   .0012 (0.18) -.0046 (0.45) -.0088 (4.68) 
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Latvia  -.0077 (1.17)  .0094 (0.86) -.0086 (4.39) 
Lithuania  -.0045 (0.67)   .0246 (2.14) -.0067 (3.19) 
Poland  -.0072 (1.10) -.0064 (0.62) -.0099 (5.40) 
Romania  -.0261 (4.56) -.0308 (3.20) -.0102 (5.54) 
Slovakia  -.0098 (1.48) -.0126 (1.22) -.0085 (4.22) 
Slovenia  -.0044 (0.64) -.0209 (2.06) -.0108 (5.39) 
Turkey  .0166 (1.98)   .0176 (1.46) -.0060 (2.68) 
Croatia -.0013 (0.19) -.0006 (0.06) -.0081 (4.08) 
Turkish Cyprus  .0180 (1.77) -.0005 (0.04) -.0072 (2.58) 
    
Pseudo R2 .0554 .0667 .0703 
N 28,958 28,985 28984 
 
Source: Eurobarometer #64.4 December 2005-January 2006. Base categories: employed; 
Belgium; and age<25. 
 
Question wording: Please indicate which ones of the following statements possibly apply to your situation.  In the 
last 12 months… 
You have received psychotherapy due to psychological or emotional health problems 
You have taken drugs due to psychological or emotional health problem 
You have been admitted to hospital due to psychological or emotional health problems.
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Chart 1.  The Unadjusted Relationship Between the Probability of Antidepressant Use and Age 
(only country dummies)
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Chart 2.  The Regression-Adjusted Relationship Between the Probability of Antidepressant Use and Age
(full set of controls, as in Column 1 of Table 2)
